APA (7th ed.) Citation

Gallagher, D. J., Cronin, A. M., Milowsky, M. I., Morris, M. J., Bhatia, J., Scardino, P. T., . . . Robson, M. E. (2012). Germline BRCA mutation does not prevent response to taxane‐based therapy for the treatment of castration‐resistant prostate cancer. BJU international, 109(5), 713-719. https://doi.org/10.1111/j.1464-410X.2011.10292.x

Chicago Style (17th ed.) Citation

Gallagher, David J., Angel M. Cronin, Matthew I. Milowsky, Michael J. Morris, Jasmine Bhatia, Peter T. Scardino, James A. Eastham, Kenneth Offit, and Mark E. Robson. "Germline BRCA Mutation Does Not Prevent Response to Taxane‐based Therapy for the Treatment of Castration‐resistant Prostate Cancer." BJU International 109, no. 5 (2012): 713-719. https://doi.org/10.1111/j.1464-410X.2011.10292.x.

MLA (9th ed.) Citation

Gallagher, David J., et al. "Germline BRCA Mutation Does Not Prevent Response to Taxane‐based Therapy for the Treatment of Castration‐resistant Prostate Cancer." BJU International, vol. 109, no. 5, 2012, pp. 713-719, https://doi.org/10.1111/j.1464-410X.2011.10292.x.